Title : Effect of moderate liver impairment on the pharmacokinetics of opicapone.

Pub. Date : 2014 Mar

PMID : 24271646






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 PURPOSE: Opicapone (OPC) is a novel catechol-O-methyltransferase (COMT) inhibitor to be used as adjunctive therapy in levodopa-treated patients with Parkinson"s disease. Levodopa catechol-O-methyltransferase Homo sapiens